The vaccine maker’s shots involve the successful Covid vaccines’ RNA technology. Health Secretary Robert F. Kennedy Jr. has ...

Moderna received a refusal-to-file letter from the FDA objecting to how it conducted a 40,000-person trial comparing its new ...

Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna has ...

By Rashika Singh Feb 11 (Reuters) - Shares of Moderna fell 10.3% premarket on Wednesday after the U.S. Food and Drug ...

In a news release late Tuesday, Moderna said it was blindsided by the FDA’s refusal, which the FDA cited as being due to the design of the company’s Phase 3 trial for its mRNA flu vaccine, dubbed mRNA ...

By Siddhi Mahatole and Gnaneshwar Rajan Feb 11 (Reuters) - The United States will take part in a World Health Organization meeting at the end of the month to determine the composition of upcoming ...

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) shares fell almost 6% after the drugmaker announced that the US Food and Drug ...

Moderna (NASDAQ: MRNA) reported fourth-quarter results Friday morning that beat Wall Street’s muted expectations, delivering ...

Wondering why this year's flu season is so bad? Doctors are urging precaution with the flu vaccine less effective this season.

The U.S. Food and Drug Administration will not review Moderna's approval application for its influenza vaccine, the company ...